Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
$25 Million Gift to Penn Medicine and Children's Hospital of Philadelphia Establishes Center for Epilepsy and Neurodevelopmental Disorders
A $25 million gift from an anonymous donor to Penn Medicine and Children’s Hospital of […]
Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A501 Gene Therapy for Danon Disease
Rocket Pharmaceuticals, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic […]
Huma, Camden Health Partners and UCLPartners launch digital-first population health programme to identify and manage cardiovascular disease
Huma Therapeutics, a leading global digital health company, today announced a partnership with Camden Health […]
CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
Avita Care Solutions Names Dr. Christopher Hall First Chief Medical Officer
Avita Care Solutions, a national healthcare services organization committed to providing comprehensive, compassionate, and inclusive […]
Tvardi Therapeutics Appoints John Kauh, M.D. as Chief Medical Officer
Tvardi Therapeutics, a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, […]
Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.
Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced the launch […]
Spectrum Science Receives Strategic Investment from Knox Lane to Fuel Continued Growth
Spectrum Science, an independent, integrated marketing, communications and media firm focused on the pharmaceutical, biotech […]
Synergy Health Partners Selects Dr. Richard L. Makowiec as Chief Surgical Officer
Synergy Health Partners, a leader in specialized hospital staffing and management models that improve access […]
TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials
TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, announces the final close of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more